OOIR: Observatory of International Research

Papers

(The TQCC of BJU International is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
COVID‐19 and urology: a comprehensive review of the literature	132
Benign prostatic hyperplasia – what do we know?	87
Slowdown of urology residents’ learning curve during the COVID‐19 emergency	86
Comparison of complications after transrectal and transperineal prostate biopsy: a national population‐based study	74
COVID‐19 pandemic – is virtual urology clinic the answer to keeping the cancer pathway moving?	68
Effect of temporal pulse shape on urinary stone phantom retropulsion rate and ablation efficiency using holmium:YAG and super‐pulse thulium fibre lasers	65
Detection and localisation of primary prostate cancer using ⁶⁸ gallium prostate‐specific membrane antigen positron emission tomography/computed tomography compared w	64
The rising worldwide impact of benign prostatic hyperplasia	62
A comparative propensity score‐matched analysis of perioperative outcomes of intracorporeal vs extracorporeal urinary diversion after robot‐assisted radical cystectomy: results from the International	60
Is off‐clamp robot‐assisted partial nephrectomy beneficial for renal function? Data from the CLOCK trial	54
The status and characteristics of urinary stone composition in China	51
Preoperative detection of Vesical Imaging‐Reporting and Data System (VI‐RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant	50
TikTok and prostate cancer: misinformation and quality of information using validated questionnaires	50
Patients with chronic prostatitis/chronic pelvic pain syndrome show T helper type 1 (Th1) and Th17 self‐reactive immune responses specific to prostate and seminal antigens and diminished semen quality	44
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation	43
Histological comparison between predictive value of preoperative 3‐T multiparametric MRI and ⁶⁸Ga‐PSMA PET/CT scan for pathological outcomes at radical prostatectomy and pelvic lymph node d	42
Information on surgical treatment of benign prostatic hyperplasia on YouTube is highly biased and misleading	42
Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score‐matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collabor	41
Impact of the SARS‐CoV‐2 virus on male reproductive health	41
The cancer multidisciplinary team meeting: in need of change? History, challenges and future perspectives	40
Robot‐assisted kidney transplantation: update from the European Robotic Urology Section (ERUS) series	40
The clinical and financial implications of a decade of prostate biopsies in the NHS: analysis of Hospital Episode Statistics data 2008–2019	39
Robot‐assisted radical prostatectomy feasibility and setting with the Hugo™ robot‐assisted surgery system	38
Prostate cancer screening and treatment: where have we come from and where are we going?	38
Rezum water vapour therapy: promising early outcomes from the first UK series	37

Deep learning approach to predict lymph node metastasis directly from primary tumour histology in prostate cancer	37
Society of Robotic Surgery review: recommendations regarding the risk of COVID‐19 transmission during minimally invasive surgery	37
Objective assessment of intraoperative skills for robot‐assisted radical prostatectomy (RARP): results from the ERUS Scientific and Educational Working Groups Metrics Initiative	35
Transperineal freehand multiparametric MRI fusion targeted biopsies under local anaesthesia for prostate cancer diagnosis: a multicentre prospective study of 1014 cases	35
Systemic therapies for metastatic hormone‐sensitive prostate cancer: network meta‐analysis	34
UpFrontPSMA: a randomized phase 2 study of sequential ¹⁷⁷Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol)	32
Retzius‐sparing robot‐assisted radical prostatectomy improves early recovery of urinary continence: a randomized, controlled, single‐blind trial with a 1‐year follow‐up	32
Guideline of guidelines: management of recurrent urinary tract infections in women	32
Prostate cancer upgrading with serial prostate magnetic resonance imaging and repeat biopsy in men on active surveillance: are confirmatory biopsies still necessary?	32
Impact of the COVID‐19 pandemic on urological practice in emergency departments in Italy	32
Prostate cancer survivorship essentials framework: guidelines for practitioners	31
Certification in reporting multiparametric magnetic resonance imaging of the prostate: recommendations of a UK consensus meeting	31
The role of novel minimally invasive treatments for lower urinary tract symptoms associated with benign prostatic hyperplasia	31
The impact of the coronavirus disease 2019 pandemic on the utilisation of emergency urological services	31
Current status of thulium fibre laser lithotripsy: an up‐to‐date review	30
International Alliance of Urolithiasis guideline on retrograde intrarenal surgery	30
The IDENTIFY study: the investigation and detection of urological neoplasia in patients referred with suspected urinary tract cancer – a multicentre observational study	30
Re: Oncological outcome according to attainment of pentafecta after robot‐assisted radical cystectomy in patients with bladder cancer in the multicentre KORARC database. BJU Int 2020 July 18. D	30
Testosterone replacement therapy reduces biochemical recurrence after radical prostatectomy	30
The cytoreductive prostatectomy in metastatic prostate cancer: what the individual trials are hoping to answer	29
Indications for and complications of pelvic lymph node dissection in prostate cancer: accuracy of available nomograms for the prediction of lymph node invasion	29
Management of benign prostatic hyperplasia in the 21st century: temporal trends in Australian population‐based data	27
Prostate cancer in transgender women: what does a urologist need to know?	27
Local anaesthetic transperineal (LATP) prostate biopsy using a probe‐mounted transperineal access system: a multicentre prospective outcome analysis	27
Early outcomes of single‐port robot‐assisted radical prostatectomy: lessons learned from the learning‐curve experience	26
Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial	26
Randomised trial of bipolar resection vs holmium laser enucleation vs Greenlight laser vapo‐enucleation of the prostate for treatment of large benign prostate obstruction: 3‐years outcomes	26
The dramatic COVID 19 outbreak in Italy is responsible of a huge drop of urological surgical activity: a multicenter observational study	25
Global challenges to urology practice during the COVID‐19 pandemic	25
Predictors of local recurrence and its impact on survival after glansectomy for penile cancer: time to challenge the dogma?	25
Every decade counts: a narrative review of functional recovery after partial nephrectomy	24
Single‐port robot‐assisted radical prostatectomy: a systematic review and pooled analysis of the preliminary experiences	24
Bolstering the surgical response to COVID‐19: how virtual technology will save lives and safeguard surgical practice	24
Cancer‐associated fibroblasts in renal cell carcinoma: implication in prognosis and resistance to anti‐angiogenic therapy	24
Non‐invasive and surgical penile enhancement interventions for aesthetic or therapeutic purposes: a systematic review	24
Impact of the COVID‐19 pandemic on the diagnosis and treatment of men with prostate cancer	24
Prostate Health Index and multiparametric magnetic resonance imaging to predict prostate cancer grade reclassification in active surveillance	24
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin‐C vs surgical management in low‐risk non‐muscle‐invasive bladder cancer	24
Association of erectile dysfunction and cardiovascular disease: an umbrella review of systematic reviews and meta‐analyses	24
The impact of racial residential segregation on prostate cancer diagnosis and treatment	24
Artificial urinary sphincter significantly better than fixed sling for moderate post‐prostatectomy stress urinary incontinence: a propensity score‐matched study	23
Surgeon heterogeneity significantly affects functional and oncological outcomes after radical prostatectomy in the Swedish LAPPRO trial	23
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non‐muscle‐invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial	23
Evidence‐based quality and accuracy of YouTube videos about nephrolithiasis	23
Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study)	23
The effect of the urinary and faecal microbiota on lower urinary tract symptoms measured by the International Prostate Symptom Score: analysis utilising next‐generation sequencing	22
Retzius‐sparing robot‐assisted radical prostatectomy: early learning curve experience in three continents	22
Rising incidence rates and unaltered survival rates for primary upper urinary tract urothelial carcinoma: a Dutch population‐based study from 1993 to 2017	22
Solitary rib lesions showing prostate‐specific membrane antigen (PSMA) uptake in pre‐treatment staging ⁶⁸Ga‐PSMA‐11 positron emission tomography scans for men with prostate cancer: benign o	22
A clinical pathway for the management of Peyronie’s disease: integrating clinical guidelines from the International Society of Sexual Medicine, American Urological Association and European Urological	22

Detection of clinically significant cancer in the anterior prostate by transperineal biopsy	22
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy	21
Holmium laser enucleation of the prostate using Moses 2.0 vs non‐Moses: a randomised controlled trial	21
Comprehensive analysis of serum chromogranin A and neuron‐specific enolase levels in localized and castration‐resistant prostate cancer	21
Comparison of the performances of the ADXBLADDER test and urinary cytology in the follow‐up of non‐muscle‐invasive bladder cancer: a blinded prospective multicentric study	21
Thulium fibre laser vs holmium: yttrium‐aluminium‐garnet laser lithotripsy for urolithiasis: meta‐analysis of clinical studies	21
Trends in clinical and oncological outcomes of robot‐assisted radical prostatectomy before and after the 2012 US Preventive Services Task Force recommendation against PSA screening: a decade of experi	20
A reflection on an adapted approach from face‐to‐face to telephone consultations in our Urology Outpatient Department during the COVID‐19 pandemic – a pathway for change to future practice?	20
Development and validation of an explainable artificial intelligence‐based decision‐supporting tool for prostate biopsy	20
Toward improved endoscopic examination of urinary stones: a concordance study between endoscopic digital pictures vs microscopy	20
A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to	20
Robot‐assisted laparoscopic artificial urinary sphincter insertion in women with stress urinary incontinence: a pilot single‐centre study	19
Tryptophan–kynurenine ratio as a biomarker of bladder cancer	19
Rezūm therapy for ≥80‐mL benign prostatic enlargement: a large, multicentre cohort study	19
Near‐infrared fluorescence imaging for intraoperative margin assessment during robot‐assisted partial nephrectomy	19
Definitive radiotherapy for extracranial oligoprogressive metastatic renal cell carcinoma as a strategy to defer systemic therapy escalation	19
Upper urinary tract pressures in endourology: a systematic review of range, variables and implications	19
Multicentre, prospective study on local treatment of metastatic prostate cancer (LoMP study)	19
Tumour location determined by preoperative MRI is an independent predictor for positive surgical margin status after Retzius‐sparing robot‐assisted radical prostatectomy	19
Pubectomy and urinary reconstruction provides definitive treatment of urosymphyseal fistula following prostate cancer treatment	19
Open vs robot‐assisted radical cystectomy (BORARC): a double‐blinded, randomised feasibility study	18
Robot‐assisted vs open radical cystectomy for bladder cancer in adults	18
Two cycles of neoadjuvant chemotherapy improves survival in patients with high‐risk upper tract urothelial carcinoma	18
Reduction of stent‐associated morbidity by minimizing stent material: a prospective, randomized, single‐blind superiority trial assessing a customized ‘suture stent’	18
NeuroSAFE frozen section during robot‐assisted radical prostatectomy: peri‐operative and histopathological outcomes from the NeuroSAFE PROOF feasibility randomized controlled trial	18
Circulating tumour DNA reveals genetic traits of patients with intraductal carcinoma of the prostate	18
Low‐intensity shockwave therapy for the management of chronic prostatitis/chronic pelvic pain syndrome: a systematic review and meta‐analysis	18
Assessment of prostate‐specific antigen screening: an evidence‐based report by the German Institute for Quality and Efficiency in Health Care	18
Minimally invasive treatments for benign prostatic hyperplasia: a Cochrane network meta‐analysis	18
ENZA‐p trial protocol: a randomized phase II trial using prostate‐specific membrane antigen as a therapeutic target and prognostic indicator in men with metastatic castration‐resistant prostate cancer	18
Survival following cytoreductive nephrectomy: a comparison of existing prognostic models	18
⁶⁸Ga‐PSMA‐PET/CT helps to select patients for salvage radical prostatectomy with local recurrence after primary radiotherapy for prostate cancer	18
Simulation in Urological Training and Education (SIMULATE): Protocol and curriculum development of the first multicentre international randomized controlled trial assessing the transferability of simu	18
Digital frozen section of the prostate surface during radical prostatectomy: a novel approach to evaluate surgical margins	17
Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma	17
Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non‐muscle‐invasive bladde	17
Implementation of frailty preoperative assessment to predict outcome in patients undergoing urological surgery: a systematic review and meta‐analysis	17
Preoperative frailty and outcome in patients undergoing radical cystectomy	17
Towards automatic recognition of pure and mixed stones using intra‐operative endoscopic digital images	17
Immune checkpoint inhibitors in advanced upper and lower tract urothelial carcinoma: a comparison of outcomes	17
Super‐mini percutaneous nephrolithotomy (PCNL) vs standard PCNL for the management of renal calculi of <2 cm: a randomised controlled study	17
Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma	17
Social media and misinformation in urology: what can be done?	16
Long‐term follow‐up after radiotherapy for prostate cancer with and without rectal hydrogel spacer: a pooled prospective evaluation of bowel‐associated quality of life	16
Robot‐assisted pyeloplasty using a new robotic system, the KangDuo‐Surgical Robot‐01: a prospective, single‐centre, single‐arm clinical study	16
Natural history of small asymptomatic kidney and residual stones over a long‐term follow‐up: systematic review over 25 years	16
Exercise training to increase tumour natural killer‐cell infiltration in men with localised prostate cancer: a randomised controlled trial	16
Comparison of STONE score, Guy’s stone score and Clinical Research Office of the Endourological Society (CROES) score as predictive tools for percutaneous nephrolithotomy outcome: a prospective study	16
Understanding virtual urology clinics: a systematic review	16
Multi‐institutional validation of a perfused robot‐assisted partial nephrectomy procedural simulation platform utilizing clinically relevant objective metrics of simulators (CROMS)	16
Targeted and systematic cognitive freehand‐guided transperineal biopsy: is there still a role for systematic biopsy?	16
Detection of clinically significant prostate cancer in biopsy‐naïve men: direct comparison of systematic biopsy, multiparametric MRI‐ and contrast‐ultrasound‐dispersion imaging‐targeted biopsy	16
A panel of systemic inflammatory response biomarkers for outcome prediction in patients treated with radical cystectomy for urothelial carcinoma	16
The BARCODE1 Pilot: a feasibility study of using germline single nucleotide polymorphisms to target prostate cancer screening	15
Multiparametric MRI‐ultrasonography software fusion prostate biopsy: initial results using a stereotactic robotic‐assisted transperineal prostate biopsy platform comparing systematic vs targeted biops	15
Morbidity and mortality after robot‐assisted radical cystectomy with intracorporeal urinary diversion in octogenarians: results from the European Association of Urology Robotic Urology Section Scienti	15
Percutaneous microwave ablation of renal masses in a UK cohort	15
Tranexamic acid in patients with complex stones undergoing percutaneous nephrolithotomy: a randomised, double‐blinded, placebo‐controlled trial	15
Trends in the use of neoadjuvant chemotherapy and oncological outcomes for high‐risk upper tract urothelial carcinoma: a multicentre retrospective study	15
Longitudinal follow‐up and performance validation of an mRNA‐based urine test (Xpert^® Bladder Cancer Monitor ) for surveillance in patients with non‐muscle‐invasive bladder cancer	15
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node‐positive penile squamous cell carcinoma	14
Prostate‐specific membrane antigen theranostics in advanced prostate cancer: an evolving option	14
Retzius‐sparing versus standard robot‐assisted laparoscopic prostatectomy for the treatment of clinically localized prostate cancer	14
Impact of circulating microRNA test (miRNA‐371a‐3p) on appropriateness of treatment and cost outcomes in patients with Stage I non‐seminomatous germ cell tumours	14
Robot‐assisted intracorporeal orthotopic bladder substitution after radical cystectomy: perioperative morbidity and oncological outcomes – a single‐institution experience	14
Oncological outcome according to attainment of pentafecta after robot‐assisted radical cystectomy in patients with bladder cancer included in the multicentre KORARC database	14
Personalised biopsy schedules based on risk of Gleason upgrading for patients with low‐risk prostate cancer on active surveillance	14
Recovery of health‐related quality of life in patients undergoing robot‐assisted radical cystectomy with intracorporeal diversion	14
Artificial intelligence to improve cytology performances in bladder carcinoma detection: results of the VisioCyt test	14
The obesity paradox: defining the impact of body mass index and diabetes mellitus for patients with non‐muscle‐invasive bladder cancer treated with bacillus Calmette–Guérin	14
Perioperative outcomes and cost of robotic vs open simple prostatectomy in the modern robotic era: results from the National Inpatient Sample	14
Transvesical robot‐assisted radical prostatectomy: initial experience and surgical outcomes	14
Environmental impact of single‐use and reusable flexible cystoscopes	13
Use of prostate‐specific membrane antigen positron‐emission tomography/CT in response assessment following upfront chemohormonal therapy in metastatic prostate cancer	13
Do we need repeat transurethral resection after en bloc resection for pathological T1 bladder cancer?	13
A modified sequential vascular control strategy in robot‐assisted level III–IV inferior vena cava thrombectomy: initial series mimicking the open ‘milking’ technique principle	13
British Association of Urological Surgeons suprapubic catheter practice guidelines – revised	13
Favourable multi‐institutional experience with penoscrotal decompression for prolonged ischaemic priapism	13
Changes in treatment and mortality in men with locally advanced prostate cancer between 2000 and 2016: a nationwide, population‐based study in Sweden	13
Perioperative continuation of aspirin, oral anticoagulants or bridging with therapeutic low‐molecular‐weight heparin does not increase intraoperative blood loss and blood transfusion rate in cystectom	13

Population‐based randomized trial of screening for clinically significant prostate cancer ProScreen: a pilot study	13
British Association of Urological Surgeons (BAUS) and Nurses (BAUN) consensus document: management of the complications of long‐term indwelling catheters	13
Complete metabolic response with [¹⁸F]fluorodeoxyglucose‐positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinic	13
Value of tumour‐infiltrating immune cells in predicting response to intravesical BCG in patients with non‐muscle‐invasive bladder cancer: a systematic review and meta‐analysis	13
A novel tool to predict functional outcomes after robot‐assisted radical prostatectomy and the value of additional surgery for incontinence	13
Management of uncomplicated recurrent urinary tract infections	13
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis	13
A systematic review on mutation markers for bladder cancer diagnosis in urine	13
Urine cell image recognition using a deep‐learning model for an automated slide evaluation system	12
Risk models for recurrence and survival after kidney cancer: a systematic review	12
DaPeCa‐7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases an	12
Cytoreductive nephrectomy and exposure to sunitinib – a post hoc analysis of the Immediate Surgery or Surgery After Sunitinib Malate in Treating Patients With Metastatic Kidney Cancer (SURTIME)	12
Magnetic resonance imaging‐guided transurethral ultrasound ablation in patients with localised prostate cancer: 3‐year outcomes of a prospective Phase I study	12
Chronic prostatitis/chronic pelvic pain syndrome: it is time to change our management and research strategy	12
Pre‐versus postnatal presentation of posterior urethral valves: a multi‐institutional experience	12
A non‐inferiority comparative analysis of micro‐ultrasonography and MRI‐targeted biopsy in men at risk of prostate cancer	12
Learning curve analysis of single‐port robot‐assisted extraperitoneal prostatectomy using the cumulative sum (CUSUM) method	12
Predicting intra‐operative and postoperative consequential events using machine‐learning techniques in patients undergoing robot‐assisted partial nephrectomy: a Vattikuti Collective Quality Initiative	12
Avoiding disruption of timely surgical management of genitourinary cancers during the early phase of the COVID‐19 pandemic	12
Not all prostate cancer is the same – patient perceptions: an Asia‐Pacific region study	12
Robot‐assisted fluoroscopy‐guided renal puncture for endoscopic combined intrarenal surgery: a pilot single‐centre clinical trial	12
Blue vs white light for transurethral resection of non‐muscle‐invasive bladder cancer: an abridged Cochrane Review	12
Urology surgical activity and COVID‐19: risk assessment at the epidemic peak: a Parisian multicentre experience	12
A risk calculator predicting recurrence in lymph node metastatic penile cancer	12
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance	12
Early detection of kidney cancer using urinary proteins: a truly non‐invasive strategy	11
Novel syphon ureteric access sheath has the potential to improve renal pressures and irrigant flow	11
A prospective, matched comparison of ultra‐low and standard‐dose computed tomography for assessment of renal colic	11
Management of large renal stones with super‐mini percutaneous nephrolithotomy: an international multicentre comparative study	11
Evaluation and understanding of automated urinary stone recognition methods	11
The prognostic value of lymph node staging with prostate‐specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and extended pelvic	11
Primary Gleason grade and Gleason grade group at positive surgical margins: a systematic review and meta‐analysis	11
Lower odds of cardiac events for gonadotrophin‐releasing hormone antagonists versus agonists	11
Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer	11
Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk	11
Spontaneous (idiopathic) rupture of the urinary bladder: a systematic review of case series and reports	11
Long‐term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis	11
British Association of Urological Surgeons (BAUS) consensus document: management of bladder and ureteric injury	11
Masculinizing surgery in disorders/differences of sex development: clinician‐ and participant‐evaluated appearance and function	11
Median 5‐year outcomes of primary focal irreversible electroporation for localised prostate cancer	11
Urinary incontinence and use of incontinence surgery after radical prostatectomy: a national study using patient‐reported outcomes	11
NeuroSAFE in radical prostatectomy increases the rate of nerve‐sparing surgery without affecting oncological outcome	11
Recurrence‐ and progression‐free survival in intermediate‐risk non‐muscle‐invasive bladder cancer: the impact of conditional evaluation and subclassification	10
Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen (⁶⁸Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological	10
Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging	10
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic reson	10
Urological stone disease: a 5‐year update of stone management using Hospital Episode Statistics	10
Stress urinary incontinence in the mesh complication era: current Australian trends	10
Prognostic scoring system and risk stratification in patients with emphysematous pyelonephritis: an 11‐year prospective study at a tertiary referral centre	10
Avoiding deep pelvic complications using a ‘Five‐Step’ technique for high submuscular placement of inflatable penile prosthesis reservoirs	10
Comparative effectiveness of neoadjuvant chemotherapy in bladder and upper urinary tract urothelial carcinoma	10
Cost‐effectiveness analysis of multiple imaging modalities in diagnosis and follow‐up of intermediate complex cystic renal lesions	10
High prostate‐specific membrane antigen (PSMA) positron emission tomography (PET) maximum standardized uptake value in men with PI‐RADS score 4 or 5 confers a high probability of	10
Considering non‐bladder aetiologies of overactive bladder: a functional neuroimaging study	10
Patterns of care for prostate cancer treatment and improving outcomes – are national registries the answer?	10
Intermediate‐ and long‐term oncological outcomes of active surveillance for localized renal masses: a systematic review and quantitative analysis	10
Prospective evaluation of blue‐light flexible cystoscopy with hexaminolevulinate in non‐muscle‐invasive bladder cancer	10
Multiparametric magnetic resonance imaging facilitates reclassification during active surveillance for prostate cancer	10
Comparing confirmatory biopsy outcomes between MRI‐targeted biopsy and standard systematic biopsy among men being enrolled in prostate cancer active surveillance	10
Idea, Development, Exploration, Assessment, Long‐term follow‐up study (IDEAL) Stage 1/2a evaluation of urological procedures with the Versius robot	10
Understanding the needs of low‐income countries: how urologists can help	10
Optimal pathological response after neoadjuvant chemotherapy for muscle‐invasive bladder cancer: results from a global, multicentre collaboration	10
Ten‐year survival outcomes after radical nephroureterectomy with a risk‐stratified approach using prior diagnostic ureteroscopy: a single‐institution observational retrospective cohort study	10
Healthcare lockdown resulted in a treatment backlog in elective urological surgery during COVID‐19	9
Racial disparities and online health information: YouTube and prostate cancer clinical trials	9
Personalised three‐dimensional printed transparent kidney model for robot‐assisted partial nephrectomy in patients with complex renal tumours (R.E.N.A.L. nephrometry score ≥7): a prospective case‐matc	9
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions	9
Robot‐assisted Boari flap and psoas hitch ureteric reimplantation: technique insight and outcomes of a case series with ≥1 year of follow‐up	9
Predictors for failure of endoscopic ureteric stenting in patients with malignant ureteric obstruction: systematic review and meta‐analysis	9
A cross‐section of UK prostate cancer diagnostics during the coronavirus disease 2019 (COVID‐19) era – a shifting paradigm?	9
A novel flexible vacuum‐assisted ureteric access sheath in retrograde intrarenal surgery	9
What influences adherence to guidance for postoperative instillation of intravesical chemotherapy to patients with bladder cancer?	9
Comprehensive review of the use of hydrogel spacers prior to radiation therapy for prostate cancer	9
Randomised comparison of techniques for control of the dorsal venous complex during robot‐assisted laparoscopic radical prostatectomy	9
Management of chronic primary pelvic pain syndromes	9
A randomized trial investigating clinical outcomes and stent‐related symptoms after placement of a complete intra‐ureteric stent on a string versus conventional stent placement	9
Challenges, applications and future directions of precision medicine in prostate cancer – the role of organoids and patient‐derived xenografts	9
Development of a patient decision aid for the surgical management of lower urinary tract symptoms secondary to benign prostatic hyperplasia	9
Percutaneous nephrolithotomy – the puncture	9
Evaluation of fluid absorption during flexible ureteroscopy in an in vivo porcine model	9
Renal oncocytoma: landscape of diagnosis and management	8
A prehabilitation programme implemented before robot‐assisted radical prostatectomy improves peri‐operative outcomes and continence recovery	8
The rapid assessment for prostate imaging and diagnosis (RAPID) prostate cancer diagnostic pathway	8
Ureteroscopy and tailored treatment of upper tract urothelial cancer: recent advances and unmet needs	8
Electronic medical records – a disappointing mirage for clinicians and research	8
Pelvic exenteration surgery in patients with locally advanced castration‐naïve and castration‐resistant, symptomatic prostate cancer	8
Low‐grade prostate cancer should still be labelled cancer	8
High diagnostic accuracy of inguinal ultrasonography and fine‐needle aspiration followed by dynamic sentinel lymph node biopsy in men with impalpable and palpable inguinal lymph nodes	8
Complications of synthetic mesh inserted for stress urinary incontinence	8
Martini‐Klinik experience of prostate cancer surgery during the early phase of the COVID‐19 pandemic	8
Magnetic resonance imaging‐guided transurethral ultrasound ablation for benign prostatic hyperplasia: 12‐month clinical outcomes of a phase I study	8
Association between one‐time prostate‐specific antigen (PSA) test with free/total PSA ratio and prostate cancer mortality: A 30‐year prospective cohort study	8
Xanthogranulomatous pyelonephritis: a systematic review of treatment and mortality in more than 1000 cases	8
Elevated preoperative C‐reactive protein is associated with renal functional decline and non‐cancer mortality in surgically treated renal cell carcinoma: analysis from the INternational Marker Consort	8
Patient‐reported outcomes after buccal mucosal graft urethroplasty for bulbar urethral strictures: results of a prospective single‐centre cohort study	8